Atherosclerosis and restenosis: Is there a role for rage? (original) (raw)
Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; National Heart, Lung and Blood Institute; Juvenile Diabetes Foundation International; National Institute of Diabetes and Digestive and Kidney Diseases; and the American Heart Association [no authors listed]. Circulation 1999, 100:1132–1133.
Kannel W: Lipids, diabetes, and coronary heart disease: insights from the Framingham study. Am Heart J 1985, 110:1100–1107. ArticlePubMedCAS Google Scholar
Stamler J, Vaccaro O, Neaton J, Wentworth D: Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 2003, 16:434–444. Article Google Scholar
Beckman J, Craeger M, Libby P: Diabetes and atherosclerosis. Epidemiology, pathophysiology and management. JAMA 2002, 287:2570–2581. ArticlePubMedCAS Google Scholar
Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group [no authors listed]. Lancet 1998, 352:837–853. Article Google Scholar
Stratton I, Adler A, Neil H, et al.: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321:405–412. ArticlePubMedCAS Google Scholar
Kastrati A, Schomig A, Elezi S, et al.: Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997, 30:1428–1436. ArticlePubMedCAS Google Scholar
Mazeika P, Prasad N, Bui S, Seidelin P: Predictors of angio-graphic restenosis after coronary intervention in patients with diabetes mellitus. Am Heart J 2003, 145:1013–1021. ArticlePubMed Google Scholar
Kornowski R, Mintz G, Kent K, et al.: Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. Circulation 1997, 95:1366–1369. PubMedCAS Google Scholar
Takagi T, Yamamuor A, Tamita K, et al.: Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study. Am Heart J 2003, 146:E5. ArticlePubMedCAS Google Scholar
Phillips J, Barringhaus K, Sander J, et al.: Rosiglitazone reduces accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes. Circulation 2003, 108:1994–1999. ArticlePubMed Google Scholar
Schmidt AM., Vianna M, Gerlach M, et al.: Isolation and characterization of binding proteins for advanced glycosylation end products from lung tissue which are present on the endothelial cell surface. J Biol Chem 1992, 267:14987–14997. PubMedCAS Google Scholar
Neeper M, Schmidt AM, Brett J, et al.: Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992, 267:14998–15004. PubMedCAS Google Scholar
Brownlee M: Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1996, 47:223–234. Google Scholar
Kislinger T, Fu C, Huber B, et al.: N(epsilon)(carboxymethyl) lysine adducts of proteins are ligands for RAGE that activate cell signalling pathways and modulate gene expression. J Biol Chem 1999, 274:31740–31749. ArticlePubMedCAS Google Scholar
Thornalley P: Cell activation by glycated proteins: AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol (Noisy-le-grand) 1998, 44:1013–1023. CAS Google Scholar
Hofmann M, Drury S, Caifeng F, et al.: RAGE mediates a novel proinflammatory axis: the cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 7:889–901. Article Google Scholar
Hori O, Brett J, Slattery T, et al.: The receptor for advanced glycation endproducts (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J Biol Chem 1995, 270:25752–25761. ArticlePubMedCAS Google Scholar
Chavakis T, Bierhaus A, Al-Fakhri N, et al.: The patter recognition receptor RAGE is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 2003, 198:1507–1515. ArticlePubMedCAS Google Scholar
Yan SD, Chen X, Fu J, et al.: RAGE in Alzheimer’s disease: a receptor mediating amyloid-beta peptide-induced oxidant stress and neurotoxicity and microglial activation. Nature 1996, 382:685–691. ArticlePubMedCAS Google Scholar
Roth J, Vogl T, Sorg C, Sunderkotter C: Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 2003, 24:155–158. ArticlePubMedCAS Google Scholar
Wang H, Bloom O, Zhang M, et al.: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248–251. ArticlePubMedCAS Google Scholar
Deane R, Yan SD, Submamaryan RK, et al.: RAGE mediates amyloid-beta peptide transport across the blood-brain, suppression of cerebral blood flow and development of cerebral amyloidosis. Nat Med 2003, 9:907–913. ArticlePubMedCAS Google Scholar
Arancio O, Zhang HP, Chen X, et al.: RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. EMBO J 2004, 23:4096–4105. ArticlePubMedCAS Google Scholar
Schmidt AM, Yan SD, Yan SF, Stern D: RAGE: a multiligand receptor serving as a progression factor amplifying the immune/ inflammatory response. J Clin Invest 2001, 108:949–955. This review article summarizes the biology of RAGE in a variety of contexts, in addition to the area of vascular disease described in the current paper. ArticlePubMedCAS Google Scholar
Bouma B, Kroon-Batenburg L, Wu YP, et al.: Glycation induces formation of amyloid cross-beta structure in albumin. J Biol Chem 2003, 278:41810–41819. ArticlePubMedCAS Google Scholar
Ishihara K, Tsutusmi K, Kawane S, et al.: RAGE directly binds to ERK by a D-domain-like docking site. FEBS Lett 2003, 550:107–113. ArticlePubMedCAS Google Scholar
Brizzi M, Dentelli P, Rosso A, et al.: RAGE- and TGF-beta receptor-mediated signals converge on STAT5 and p21waf to control cell-cycle progression of mesangial cells: a possible role in the development and progression of diabetic nephropathy. FASEB J 2004, 18:1249–1251. PubMedCAS Google Scholar
Shaw SS, Schmidt AM, Banes AK, et al.: S100B-RAGE-mediated augmentation of angiotensin ii-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. Diabetes 2003, 52:2381–2388. ArticlePubMedCAS Google Scholar
Li J, Huang X, Zhu H, et al.: AGEs activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. FASEB J 2004, 18:176–178. ArticlePubMedCAS Google Scholar
Huttunen H, Fages C, Rauvala H: RAGE-mediate neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999, 274:19919–19924. ArticlePubMedCAS Google Scholar
Wautier MP, Chappey O, Corda S, et al.: Activation of NADPH oxidase by AGEs links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001, 280:E685-E694. PubMedCAS Google Scholar
Wells-Knecht K, Zyzak D, Litchfield J, et al.: Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 1995, 21:3702–3709. Article Google Scholar
Nagai R, Ikeda K, Highashi T, et al.: Hydroxyl radical mediates N-epsilon-(carboxymethyl)lysine formation from Amadori product. Biochem Biophys Res Commun 1997, 234:167–172. ArticlePubMedCAS Google Scholar
Fu M, Requena J, Jenkins A, et al.: The AGE, N-epsilon- (carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996, 271:9982–9986. ArticlePubMedCAS Google Scholar
Nagai R, Unno Y, Hayashi M, et al.: Peroxynitrite induces formation of N(epsilon)-(carboxymethyl)lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite. Diabetes 2002, 51:2833–2839. ArticlePubMedCAS Google Scholar
Anderson M, Requena, J, Crowley J, et al.: The myeloperoxidase system of human phagocytes generates N-epsilon-(carboxymethyl) lysine on proteins: a mechanism for producing AGEs at sites of inflammation. J Clin Invest 1999, 104:103–113. ArticlePubMedCAS Google Scholar
Schalkwijk C, Baidoshvili A, Stehouwer C, et al.: Increased accumulation of the glycoxidation product N(epsilon)- (carboxymethyl)lysine in hearts of diabetic patients; generation and characterization of a monoclonal anti-CML antibody. Biochim Biophys Acta 2004, 1636:82–89. PubMedCAS Google Scholar
Nerlich A, Schleicher E: N-epsilon-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress. Atherosclerosis 1999, 144:41–47. ArticlePubMedCAS Google Scholar
Park L, Raman K, Lee K, et al.: Suppression of accelerated diabetic atherosclerosis by soluble receptor for AGE (sRAGE). Nat Med 1998, 4:1025–1031. ArticlePubMedCAS Google Scholar
Wautier JL, Zoukourian C, Chappey O, et al.: Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation end products blocks hyperpermeability. J Clin Invest 1996, 97:238–243. PubMedCAS Google Scholar
Kislinger T, Tanji N, Wendt T, et al.: Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in the vasculature of diabetic apolipoprotein E null mice. Arterioscler Thromb Vasc Biol 2001, 21:905–910. PubMedCAS Google Scholar
Bucciarelli LG, Wendt T, Qu W, et al.: RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 2002, 106:2827–2835. ArticlePubMedCAS Google Scholar
Moreno P, Fallon J, Murcia A, et al.: Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients. J Am Coll Cardiol 1999, 34:1045–1049. ArticlePubMedCAS Google Scholar
Sakaguchi T, Yan SF, Yan SD, et al.: Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 2003, 111:959–972. ArticlePubMedCAS Google Scholar
Seki Y, Kai H, Shibata R, et al.: Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury. Circ Res 2000, 87:12–18. PubMedCAS Google Scholar
Zhou A, Wang K, Penn MS, et al.: Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 2003, 107:2238–2243. The authors report on a model carotid artery de-endothelialization in which diabetic (type 2) rats develop more extensive neointimal expansion than nondiabetic animals. This model system is likely to be useful to others studying mechanisms of vascular dysfunction in the context of diabetes. ArticlePubMedCAS Google Scholar
Liliensiek B, Weigand MA, Bierhaus A, et al.: Receptor for advanced glycation end products (RAGE) regulating sepsis but not the adaptive immune response. J Clin Invest 2004, 113:1641–1650. This paper describes the role of RAGE in innate immunity, based on studies showing a protective phenotype in the setting of Escherichia coli sepsis (cecal ligation and puncture) compared with control animals. ArticlePubMedCAS Google Scholar
Park J, Svetkauskaite D, He Q, et al.: Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Bio Chem 2004, 279:7370–7377. ArticleCAS Google Scholar
Fujita T, Asai T, Andrassy M, et al.: PKCbeta regulates ischemia/ reperfusion injury in the lung. J Clin Invest 2004, 113:1615–1623. ArticlePubMedCAS Google Scholar
Yan SF, Fujita T, Lu J, et al.: EGR-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000, 6:1355–1361. ArticlePubMedCAS Google Scholar
Yan SF, Lu J, Zou YS, et al.: Protein kinase C-beta and oxygen deprivation: a novel Egr-1-dependent pathway for fibrin deposition in hypoxemic vasculature. J Biol Chem 2000, 275:11921–11928. ArticlePubMedCAS Google Scholar